Chemoinformetrical evaluation of dissolution property of indomethacin tablets by near-infrared spectroscopy

Journal of Pharmaceutical Sciences

Volumn 96, Issue 4, 2007, Pages 788-801

  Otsuka, Makoto ^a   Tanabe, Hideaki ^b   Osaki, Kazuo ^c   Otsuka, Kuniko ^d   Ozaki, Yukihiro ^e  

^a MUSASHINO UNIVERSITY   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c Nihon Buchi KK   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e KWANSEI GAKUIN UNIVERSITY   (Japan)

Author keywords

Chemoinformetrics; Physical characterization; Preformulation study; Principal component analysis; Reflectance near infrared spectroscopy; Tablet dissolution test; Transmittance near infrared spectroscopy

Indexed keywords

CELLULOSE; INDOMETACIN; LACTOSE; MAGNESIUM STEARATE;

ARTICLE; DISSOLUTION; DRUG FORMULATION; NEAR INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY; TABLET; TABLET COMPRESSION;

EID: 34247516916     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20704     Document Type: Article

References (35)

1. Anonymous. 2002. In: Paulson W, editor. Regulatory leeway sought for process analytical technology. The Gold Sheet, Vol. 36. Chevy Chase, MD: Elsevier.
2. Process Analytical Technology (PAT) Initiative. U.S. Food and Drug Administration Center for Drug Evaluation and Research Home Page (http:// www.fda.gov/cder/OPS/PAT.htm).
3. Higgins JP, Arrivo SM, Thurau G, Green RL, Bowen W, Lange A, Templeton AC, Thomas DL, Reed RA. 2003. Spectroscopic approach for on-line monitoring of particle size during the processing of pharmaceutical nanoparticles. Anal Chem 75: 1777-1785.
4. Siesler HW, Ozaki Y, Kawano S, Heise HM. 2001. Near-infrared spectroscopy: Principles, instruments, applications. Weinheim: Wiley-VCH.
5. Martents H, Naes T. 1989. Multivariate calibration. New York: John Wiley & Sons.
6. Buchanan BR, Baxter MA, Chen TS, Qin XZ, Robinson PA. 1996. Use of near-infrared spectroscopy to evaluate an active in a film coated tablet. Pharm Res 13:616-621.
7. Drennen JK, Lodder RA. 1990. Nondestructive near-infrared analysis of intact tablets for determination of degradation products. J Pharm Sci 79: 622-627.
8. Norris T, Aldridge PK, Sekulic SS. 1997. Determination of end-points for polymorph conversions of crystalline organic compounds using on-line near-infrared spectroscopy. Analyst 122:549-552.
9. Saver RW, Meulman PA, Bowerman DK, Havens JL. 1998. Factor analysis of infrared spectra for solid-state forms of delavirdine mesylate. Int J Pharm 167:105-120.
10. Patl AD, Luner PE, Kemper MS. 2000. Quantitative analysis of polymorphs in binary and multi-component powder mixtures by near-infrared reflectance spectroscopy. Int J Pharm 206:63-74.
11. Otsuka M, Kato F, Matsuda Y. 2000. Comparative evaluation of the degree of indomethacin crystallinity by chemoinfometrical fourier-transformed near-infrared spectroscopy and conventional powder X-ray diffractometry. AAPS Pharmsci 2:1-8 (article 9).
12. Otsuka M, Kato F, Matsuda Y. 2001. Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry. Analyst 126:1578-1582.
13. Bull CR. 1991. Compensation for particle size effects in near infrared reflectance. Analyst 116: 781-786.
14. Aucott LS, Garthwaite PH, Paul H, Buckland S. 1988. Transformations to reduce the effect of particle size in near-infrared spectra. Analyst 113: 1849-1854.
15. Norris KH, Williams PC. 1984. Optimization of mathematical treatments of raw near-infrared signal in the measurement of protein in hard red spring wheat, I. Influence of particle size. Cereal Chem 61:158-165.
16. Franke P, Gill I, Luscombe CN, Rudd DR, Waterhouse J, Jayasooriya A. 1998. Near-infrared mass median particle size determination of lactose monohydrate. Evaluating several chemometric approaches. Analyst 123:2043-2046.
17. Otsuka M, Mouri Y, Matsuda Y. 2003. Chemometric evaluation of pharmaceutical properties of antipyrine granules by near-infrared spectroscopy. AAPS PharmSciTech 4:334-340 (article 42) (http:// www.pharmascitech.org).
18. Otsuka M. 2004. Comparative particle size determination of phenacetin bulk powder by using Kubelka-Munk theory and principle component regression analysis based on near-infrared spectroscopy. Powder Tech 141:244-250.
19. Morisseau KM, Rhodes CT. 1997. Near-infrared spectroscopy as a nondestructive alternative to conventional tablet hardness testing. Pharm Res 14:108-111.
20. Kirsch JD, Drennen JK. 1999. Nondestructive tablet hardness testing by near-infrared spectroscopy: A new and robust spectral best-fit algorithm. J Pharm Biomed Anal 19:351-362.
21. Ebube NK, Thosar SS, Roberts RA, Kemper MS, Rubnovitz R, Martin DL, Reier GE, Wheatley TA, Shukala AJ. 1999. Application of near-infrared spectroscopy for nondestructive analysis of Avicel powders and tablets. Pharm Dev Tech 4:19-26.
22. Chen Y, Thosar SS, Forbess RA, Kemper MS, Rubinovitz RL, Shukla AJ. 2001. Prediction of drug content and hardness of intact tablets using artificial neural network and near-infrared spectroscopy. Drug Dev Ind Pharm 27:623-631.
23. Otsuka M, Yamane I. 2006. Prediction of tablet hardness based on near infrared spectra of raw mixed powders by chemoinformetrics. J Pharm Sci 95:1425-1433.
24. Chowhan ZT, Chi LH. 1986. Drug-excipient interactions resulting from powder mixing IV: Role of lubricants and their effect on in-vitro dissolution. J Pharm Sci 75:542-545.
25. Ebian AEAR, Fikrat HT, Moustafa RMA, Abul-Enin EB. 1986. Nitrofurantoin II. Correlation of in vivo bioavailability to in vitro dissolution of nitrofurantoin tablets aged at different relative humidities and elevated temperatures. Egypt J Pharm Sci 27:347-358.
26. Otsuka M, Gao J, Matsuda Y. 1993. Effects of mixer and mixing time on the pharmaceutical properties of theophylline tablets containing various kinds of lactqse as diluents. Drug Dev Ind Pharm 19:333-348.
27. Kikuta J, Kitamori N. 1994. Effect of mixing time on the lubricating properties of magnesium stea-rate and the final characteristics of the compressed tablet. Drug Dev Ind Pharm 20:343-355.
28. Zannikos PN, Li W, Drennen JK, Lodder RA. 1991. Spectrophotometirc prediction of the dissolution rate of carbamazepine tablets. Pharm Res 8:974-978.
29. Washburn EW. 1921. The dynamics of capillary flow. Am Phys Soc 17:374-375.
30. Takayama K, Nambu N, Nagai T. 1982. Factors affecting the dissolution of indomethacin dispersed in various water-soluble polymers. Chem Pharm Bull 30:673-678.
31. Tanigawara Y, Yamakoka K, Nakagawa T, Uno T. 1982. Moment analysis for the separation of mean in vivo disintegration, dissolution, absorption, and disposition time of ampicillin products. J Pharm Sci 71:1129-1133.
32. Prouette manual. Multivariate Data Analysis for Windows 95/98 and NT. Version 2.6, Infometrix, Inc., Woodinville, WA, USA, (http://www.infometrix.com) .
33. Otsuka M, Kato F, Matsuda Y. 2001. Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder X-ray diffractometry. Analyst 126:1578-1582.
34. Tuchikawa S. 2003. Application of time-of-flight near infrared spectroscopy to wood. In: Tuchikawa S, editor. Useful and advanced information in the field of near infrared spectroscopy. Trivandrum, India: Reseach Signpost. pp 293-307.
35. Otsuka M, Hasegawa H, Matsuda Y. 1997. Effect of polymorphic transformation during the extrusion-granulation process on pharmaceutical properties of carbamazepine granules. Chem Pharm Bull 45: 894-898.